Abstract
Solid organ transplantation is a life saving procedure for patients with end-stage organ disease, and great care is taken to ensure that healthy organs are procured from deceased or live donors. Despite rigorous efforts to avoid injury, all organs experience some degree of damage from a process called ischemia reperfusion injury (IRI). The first part of the injury (ischemia) occurs when the donor organ's blood supply is compromised, and the second part (reperfusion) occurs when the blood supply is reestablished. The pathophysiology of the IRI is complex, but data from many laboratories have demonstrated that the inciting events of ischemia/reperfusion injury are triggered through a phylogenetically conserved system called the innate immune system. The innate immune system is a complex array of molecules, receptors and cellular elements present in species as diverse as plants to humans. This review discusses the role of the innate immune system in renal IRI and focuses on mechanisms of injury during organ procurement and transplantation. Although there are overlapping complex mechanisms, blockade of the innate immune system will likely provide a novel approach to preventing the earliest events associated with renal ischemia. Potentially, blockade of innate immune activation will provide the opportunity to increase the use marginal donors, especially those from patients deceased after cardiac death.
Similar content being viewed by others
References
Agrawal A, Gurusamy K, Powis S, Gray DW, Fuller B, Davidson BR (2008) A meta-analysis of the impact of the two-layer method of preservation on human pancreatic islet transplantation. Cell Transplant 17:1315–1322
Akira S (2003) Mammalian toll-like receptors. Curr Opin Immunol 15:5–11
Akira S, Takeda K (2004) Toll-like receptor signalling. Nat Rev Immunol 4:499–511
Anders HJ, Banas B, Linde Y, Weller L, Cohen CD, Kretzler M, Martin S, Vielhauer V, Schlondorff D, Grone HJ (2003) Bacterial CpG-DNA aggravates immune complex glomerulonephritis: role of TLR9-mediated expression of chemokines and chemokine receptors. J Am Soc Nephrol 14:317–326
Arbibe L, Mira JP, Teusch N, Kline L, Guha M, Mackman N, Godowski PJ, Ulevitch RJ, Knaus UG (2000) Toll-like receptor 2-mediated NF-kappa B activation requires a Rac1-dependent pathway. Nat Immunol 1:533–540
Ascon DB, Lopez-Briones S, Liu M, Ascon M, Savransky V, Colvin RB, Soloski MJ, Rabb H (2006) Phenotypic and functional characterization of kidney-infiltrating lymphocytes in renal ischemia reperfusion injury. J Immunol 177:3380–3387
Ascon DB, Ascon M, Satpute S, Lopez-Briones S, Racusen L, Colvin RB, Soloski MJ, Rabb H (2008) Normal mouse kidneys contain activated and CD3+CD4-CD8-double-negative T lymphocytes with a distinct TCR repertoire. J Leukoc Biol 84:1400–1409
Bajwa A, Kinsey GR, Okusa MD (2009) Immune mechanisms and novel pharmacological therapies of acute kidney injury. Curr Drug Targets 10:1196–1204
Banas MC, Banas B, Hudkins KL, Wietecha TA, Iyoda M, Bock E, Hauser P, Pippin JW, Shankland SJ, Smith KD, Stoelcker B, Liu G, Grone HJ, Kramer BK, Alpers CE (2008) TLR4 links podocytes with the innate immune system to mediate glomerular injury. J Am Soc Nephrol 19:704–713
Barker CF, Billingham RE (1971) The lymphatic status of hamster cheek pouch tissue in relation to its properties as a graft and as a graft site. J Exp Med 133:620–639
Barklin A (2009) Systemic inflammation in the brain-dead organ donor. Acta Anaesthesiol Scand 53:425–435
Barrat FJ, Meeker T, Chan JH, Guiducci C, Coffman RL (2007) Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms. Eur J Immunol 37:3582–3586
Barton GM, Kagan JC, Medzhitov R (2006) Intracellular localization of Toll-like receptor 9 prevents recognition of self DNA but facilitates access to viral DNA. Nat Immunol 7:49–56
Baskin-Bey ES, Washburn K, Feng S, Oltersdorf T, Shapiro D, Huyghe M, Burgart L, Garrity-Park M, van Vilsteren FG, Oliver LK, Rosen CB, Gores GJ (2007) Clinical trial of the pan-caspase inhibitor, IDN-6556, in human liver preservation injury. Am J Transplant 7:218–225
Bernhardt WM, Gottmann U, Doyon F, Buchholz B, Campean V, Schodel J, Reisenbuechler A, Klaus S, Arend M, Flippin L, Willam C, Wiesener MS, Yard B, Warnecke C, Eckardt KU (2009) Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model. Proc Natl Acad Sci USA 106:21276–21281
Bessems M, Doorschodt BM, van Marle J, Vreeling H, Meijer AJ, van Gulik TM (2005) Improved machine perfusion preservation of the non-heart-beating donor rat liver using Polysol: a new machine perfusion preservation solution. Liver Transplant 11:1379–1388
Beutler B (2009) Microbe sensing, positive feedback loops, and the pathogenesis of inflammatory diseases. Immunol Rev 227:248–263
Beutler BA (2009) TLRs and innate immunity. Blood 113:1399–1407
Billingham RE (1971) The passenger cell concept in transplantation immunology. Cell Immunol 2:1–12
Blasius AL, Beutler B (2010) Intracellular toll-like receptors. Immunity 32:305–315
Bonventre JV, Zuk A (2004) Ischemic acute renal failure: an inflammatory disease? Kidney Int 66:480–485
Boone DL, Turer EE, Lee EG, Ahmad RC, Wheeler MT, Tsui C, Hurley P, Chien M, Chai S, Hitotsumatsu O, McNally E, Pickart C, Ma A (2004) The ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responses. Nat Immunol 5:1052–1060
Bouma HR, Ploeg RJ, Schuurs TA (2009) Signal transduction pathways involved in brain death-induced renal injury. Am J Transplant 9:989–997
Brown HJ, Lock HR, Sacks SH, Robson MG (2006) TLR2 stimulation of intrinsic renal cells in the induction of immune-mediated glomerulonephritis. J Immunol 177:1925–1931
Brown HJ, Sacks SH, Robson MG (2006) Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis. J Am Soc Nephrol 17:1931–1939
Brown HJ, Lock HR, Wolfs TG, Buurman WA, Sacks SH, Robson MG (2007) Toll-like receptor 4 ligation on intrinsic renal cells contributes to the induction of antibody-mediated glomerulonephritis via CXCL1 and CXCL2. J Am Soc Nephrol 18:1732–1739
Carneiro LA, Magalhaes JG, Tattoli I, Philpott DJ, Travassos LH (2008) Nod-like proteins in inflammation and disease. J Pathol 214:136–148
Cassel SL, Eisenbarth SC, Iyer SS, Sadler JJ, Colegio OR, Tephly LA, Carter AB, Rothman PB, Flavell RA, Sutterwala FS (2008) The Nalp3 inflammasome is essential for the development of silicosis. Proc Natl Acad Sci USA 105:9035–9040
Chatterjee PK, Zacharowski K, Cuzzocrea S, Otto M, Thiemermann C (2000) Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 14:641–651
Chiao H, Kohda Y, McLeroy P, Craig L, Housini I, Star RA (1997) Alpha-melanocyte-stimulating hormone protects against renal injury after ischemia in mice and rats. J Clin Invest 99:1165–1172
Christensen SR, Shupe J, Nickerson K, Kashgarian M, Flavell RA, Shlomchik MJ (2006) Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus. Immunity 25:417–428
Codas R, Petruzzo P, Morelon E, Lefrancois N, Danjou F, Berthillot C, Contu P, Espa M, Martin X, Badet L (2009) IGL-1 solution in kidney transplantation: first multi-center study. Clin Transplant 23:337–342
Corps CL, Shires M, Crellin D, Smolenski R, Pratt J, Potts D, Lodge JP (2009) Histidine-tryptophan-ketoglutarate and delayed graft function after prolonged cold ischemia. Transplant Proc 41:3567–3570
Cravedi P, Ruggenenti P, Remuzzi G (2010) Sirolimus for calcineurin inhibitors in organ transplantation: contra. Kidney Int 78:1068–1074
Day YJ, Huang L, Ye H, Linden J, Okusa MD (2005) Renal ischemia-reperfusion injury and adenosine 2A receptor-mediated tissue protection: role of macrophages. Am J Physiol Ren Physiol 288:F722–F731
De Greef KE, Ysebaert DK, Dauwe S, Persy V, Vercauteren SR, Mey D, De Broe ME (2001) Anti-B7-1 blocks mononuclear cell adherence in vasa recta after ischemia. Kidney Int 60:1415–1427
Dickens BM (1998) Legal developments in transplantation. Ann Transplant 3:30–37
Diepenhorst GM, van Gulik TM, Hack CE (2009) Complement-mediated ischemia-reperfusion injury: lessons learned from animal and clinical studies. Ann Surg 249:889–899
Doucet C, Milin S, Favreau F, Desurmont T, Manguy E, Hebrard W, Yamamoto Y, Mauco G, Eugene M, Papadopoulos V, Hauet T, Goujon JM (2008) A p38 mitogen-activated protein kinase inhibitor protects against renal damage in a non-heart-beating donor model. Am J Physiol Ren Physiol 295:F179–F191
DuBose J, Salim A (2008) Aggressive organ donor management protocol. J Intensive Care Med 23:367–375
Edgtton KL, Kausman JY, Li M, O'Sullivan K, Lo C, Hutchinson P, Yagita H, Holdsworth SR, Kitching AR (2008) Intrarenal antigens activate CD4+ cells via co-stimulatory signals from dendritic cells. J Am Soc Nephrol 19:515–526
Feng S (2010) Donor intervention and organ preservation: where is the science and what are the obstacles? Am J Transplant 10:1155–1162
Fleming SD, Shea-Donohue T, Guthridge JM, Kulik L, Waldschmidt TJ, Gipson MG, Tsokos GC, Holers VM (2002) Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire. J Immunol 169:2126–2133
Franchi L, Warner N, Viani K, Nunez G (2009) Function of Nod-like receptors in microbial recognition and host defense. Immunol Rev 227:106–128
Fridell JA, Mangus RS, Tector AJ (2009) Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: a review of recent literature. Clin Transplant 23:305–312
Friedewald JJ, Rabb H (2004) Inflammatory cells in ischemic acute renal failure. Kidney Int 66:486–491
Fuller TF, Freise CE, Serkova N, Niemann CU, Olson JL, Feng S (2003) Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 76:1594–1599
Fuller TF, Hoff U, Kong L, Naether M, Wagner P, Nieminen-Kelha M, Nolting J, Luft FC, Hegner B, Dragun D (2010) Cytoprotective actions of FTY720 modulate severe preservation reperfusion injury in rat renal transplants. Transplantation 89:402–408
Gay NJ, Gangloff M (2007) Structure and function of Toll receptors and their ligands. Annu Rev Biochem 76:141–165
Geuken E, Buis CI, Visser DS, Blokzijl H, Moshage H, Nemes B, Leuvenink HG, de Jong KP, Peeters PM, Slooff MJ, Porte RJ (2005) Expression of heme oxygenase-1 in human livers before transplantation correlates with graft injury and function after transplantation. Am J Transplant 5:1875–1885
Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT (2008) The NALP3 inflammasome is involved in the innate immune response to amyloid-beta. Nat Immunol 9:857–865
Haug CE, Colvin RB, Delmonico FL, Auchincloss H Jr, Tolkoff-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB (1993) A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 55:766–772, discussion 772–763
He W, Liu K, Ding H (2010) The relationship between transforming growth factor beta1 expression and cold ischemia injury of rat donor kidney. Exp Mol Pathol 88:206–209
Hernandez-Alejandro R, Caumartin Y, Chent C, Levstik MA, Quan D, Muirhead N, House AA, McAlister V, Jevnikar AM, Luke PP, Wall W (2010) Kidney and liver transplants from donors after cardiac death: initial experience at the London Health Sciences Centre. Can J Surg 53:93–102
Hisamatsu T, Suzuki M, Reinecker HC, Nadeau WJ, McCormick BA, Podolsky DK (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124:993–1000
Hochegger K, Schatz T, Eller P, Tagwerker A, Heininger D, Mayer G, Rosenkranz AR (2007) Role of alpha/beta and gamma/delta T cells in renal ischemia-reperfusion injury. Am J Physiol Ren Physiol 293:F741–F747
Hori Y, Yamada K, Hanafusa N, Okuda T, Okada N, Miyata T, Couser WG, Kurokawa K, Fujita T, Nangaku M (1999) Crry, a complement regulatory protein, modulates renal interstitial disease induced by proteinuria. Kidney Int 56:2096–2106
Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E (2008) Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9:847–856
Hosgood SA, Barlow AD, Yates PJ et al. (2010) A pilot study assessing the feasibility of a short period of normothermic preservation in an experimental model of non heart beating donor kidneys. J Surg Res (in press)
Huet PM, Nagaoka MR, Desbiens G, Tarrab E, Brault A, Bralet MP, Bilodeau M (2004) Sinusoidal endothelial cell and hepatocyte death following cold ischemia-warm reperfusion of the rat liver. Hepatology 39:1110–1119
Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V, Finkel Y, Cortot A, Modigliani R, Laurent-Puig P, Gower-Rousseau C, Macry J, Colombel JF, Sahbatou M, Thomas G (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599–603
Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P (2005) Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: role of tumor necrosis factor-alpha. Am J Pathol 167:47–58
Hysi P, Kabesch M, Moffatt MF, Schedel M, Carr D, Zhang Y, Boardman B, von Mutius E, Weiland SK, Leupold W, Fritzsch C, Klopp N, Musk AW, James A, Nunez G, Inohara N, Cookson WO (2005) NOD1 variation, immunoglobulin E and asthma. Hum Mol Genet 14:935–941
Ikeda T, Yanaga K, Kishikawa K, Kakizoe S, Shimada M, Sugimachi K (1992) Ischemic injury in liver transplantation: difference in injury sites between warm and cold ischemia in rats. Hepatology 16:454–461
Imamura R, Isaka Y, Sandoval RM et al. (2010) Intravital 2-photon microscopy assessment of renal protection efficacy of siRNA for p53 in experimental rat kidney transplantation models. Cell Transplant (in press)
Iyer SS, Pulskens WP, Sadler JJ, Butter LM, Teske GJ, Ulland TK, Eisenbarth SC, Florquin S, Flavell RA, Leemans JC, Sutterwala FS (2009) Necrotic cells trigger a sterile inflammatory response through the Nlrp3 inflammasome. Proc Natl Acad Sci USA 106:20388–20393
Jang HR, Ko GJ, Wasowska BA, Rabb H (2009) The interaction between ischemia-reperfusion and immune responses in the kidney. J Mol Med 87:859–864
Jang HR, Rabb H (2009) The innate immune response in ischemic acute kidney injury. Clin Immunol 130:41–50
Jin MS, Lee JO (2008) Structures of TLR-ligand complexes. Curr Opin Immunol 20:414–419
Jo SK, Sung SA, Cho WY, Go KJ, Kim HK (2006) Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 21:1231–1239
Kanazawa N, Okafuji I, Kambe N, Nishikomori R, Nakata-Hizume M, Nagai S, Fuji A, Yuasa T, Manki A, Sakurai Y, Nakajima M, Kobayashi H, Fujiwara I, Tsutsumi H, Utani A, Nishigori C, Heike T, Nakahata T, Miyachi Y (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-kappaB activation: common genetic etiology with Blau syndrome. Blood 105:1195–1197
Kantor AB, Herzenberg LA (1993) Origin of murine B cell lineages. Annu Rev Immunol 11:501–538
Kawai T, Akira S (2007) TLR signaling. Semin Immunol 19(1):24–32
Kawai T, Akira S (2009) The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol 21:317–337
Kazemeyni SM, Esfahani F (2008) Influence of hypernatremia and polyuria of brain-dead donors before organ procurement on kidney allograft function. J Urol 5:173–177
Ke B, Shen XD, Lassman CR, Gao F, Busuttil RW, Kupiec-Weglinski JW (2003) Cytoprotective and antiapoptotic effects of IL-13 in hepatic cold ischemia/reperfusion injury are heme oxygenase-1 dependent. Am J Transplant 3:1076–1082
Kellum JA, Venkataraman R, Powner D, Elder M, Hergenroeder G, Carter M (2008) Feasibility study of cytokine removal by hemoadsorption in brain-dead humans. Crit Care Med 36:268–272
Kinsey GR, Sharma R, Huang L, Li L, Vergis AL, Ye H, Ju ST, Okusa MD (2009) Regulatory T cells suppress innate immunity in kidney ischemia-reperfusion injury. J Am Soc Nephrol 20:1744–1753
Ko GJ, Boo CS, Jo SK, Cho WY, Kim HK (2008) Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 23:842–852
Komori HK, Meehan TF, Havran WL (2006) Epithelial and mucosal gamma delta T cells. Curr Opin Immunol 18:534–538
Kono DH, Haraldsson MK, Lawson BR, Pollard KM, Koh YT, Du X, Arnold CN, Baccala R, Silverman GJ, Beutler BA, Theofilopoulos AN (2009) Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus. Proc Natl Acad Sci USA 106:12061–12066
Kotsch K, Francuski M, Pascher A, Klemz R, Seifert M, Mittler J, Schumacher G, Buelow R, Volk HD, Tullius SG, Neuhaus P, Pratschke J (2006) Improved long-term graft survival after HO-1 induction in brain-dead donors. Am J Transplant 6:477–486
Kotsch K, Ulrich F, Reutzel-Selke A, Pascher A, Faber W, Warnick P, Hoffman S, Francuski M, Kunert C, Kuecuek O, Schumacher G, Wesslau C, Lun A, Kohler S, Weiss S, Tullius SG, Neuhaus P, Pratschke J (2008) Methylprednisolone therapy in deceased donors reduces inflammation in the donor liver and improves outcome after liver transplantation: a prospective randomized controlled trial. Ann Surg 248:1042–1050
Kouwenhoven EA, de Bruin RW, Bajema IM, Marquet RL, Ijzermans JN (2001) Cold ischemia augments allogeneic-mediated injury in rat kidney allografts. Kidney Int 59:1142–1148
Lafferty KJ, Cooley MA, Woolnough J, Walker KZ (1975) Thyroid allograft immunogenicity is reduced after a period in organ culture. Science 188:259–261
Lafyatis R, Marshak-Rothstein A (2007) Toll-like receptors and innate immune responses in systemic lupus erythematosus. Arthritis Res Ther 9:222
Lakkis FG, Arakelov A, Konieczny BT, Inoue Y (2000) Immunologic 'ignorance' of vascularized organ transplantation in the absence of secondary lymphoid tissue. Nat Med 6:686–688
Latz E, Schoenemeyer A, Visintin A, Fitzgerald KA, Monks BG, Knetter CF, Lien E, Nilsen NJ, Espevik T, Golenbock DT (2004) TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat Immunol 5:190–198
Lecine P, Esmiol S, Metais JY, Nicoletti C, Nourry C, McDonald C, Nunez G, Hugot JP, Borg JP, Ollendorff V (2007) The NOD2-RICK complex signals from the plasma membrane. J Biol Chem 282:15197–15207
Li J, Gong Q, Zhong S et al. (2010) Neutralization of the extracellular HMGB1 released by ischaemic damaged renal cells protects against renal ischaemia-reperfusion injury. Nephrol Dial Transplant (in press)
Li Z, Nickkholgh A, Yi X, Bruns H, Gross ML, Hoffmann K, Mohr E, Zorn M, Buchler MW, Schemmer P (2009) Melatonin protects kidney grafts from ischemia/reperfusion injury through inhibition of NF-kB and apoptosis after experimental kidney transplantation. J Pineal Res 46:365–372
Lieberthal W, Fuhro R, Andry CC, Rennke H, Abernathy VE, Koh JS, Valeri R, Levine JS (2001) Rapamycin impairs recovery from acute renal failure: role of cell-cycle arrest and apoptosis of tubular cells. Am J Physiol Ren Physiol 281:F693–F706
Lutz J, le Luong A, Strobl M, Deng M, Huang H, Anton M, Zakkar M, Enesa K, Chaudhury H, Haskard DO, Baumann M, Boyle J, Harten S, Maxwell PH, Pusey C, Heemann U, Evans PC (2008) The A20 gene protects kidneys from ischaemia/reperfusion injury by suppressing pro-inflammatory activation. J Mol Med 86:1329–1339
Lutz J, Thurmel K, Heemann U (2010) Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation. J Inflamm 7:27
Maio R, Sepodes B, Patel NS et al (2010) Erythropoietin preserves the integrity and quality of organs for transplantation after cardiac death. Shock 35:126–133
Mangino MJ, Ametani M, Szabo C, Southard JH (2004) Poly(ADP-ribose) polymerase and renal hypothermic preservation injury. Am J Physiol Ren Physiol 286:F838–F847
Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, Dixit VM (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440:228–232
Marriott I, Rati DM, McCall SH, Tranguch SL (2005) Induction of Nod1 and Nod2 intracellular pattern recognition receptors in murine osteoblasts following bacterial challenge. Infect Immun 73:2967–2973
Martin DR, Lewington AJ, Hammerman MR, Padanilam BJ (2000) Inhibition of poly(ADP-ribose) polymerase attenuates ischemic renal injury in rats. Am J Physiol Regul Integr Comp Physiol 279:R1834–R1840
Martinon F, Burns K, Tschopp J (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10:417–426
Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237–241
Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265
Mascia L, Mastromauro I, Viberti S, Vincenzi M, Zanello M (2009) Management to optimize organ procurement in brain dead donors. Minerva Anestesiol 75:125–133
McAnulty JF (2010) Hypothermic organ preservation by static storage methods: Current status and a view to the future. Cryobiology 60:S13–S19
McKay D, Shigeoka A, Rubinstein M, Surh C, Sprent J (2006) Simultaneous deletion of MyD88 and Trif delays major histocompatibility and minor antigen mismatch allograft rejection. Eur J Immunol 36:1994–2002
Miceli-Richard C, Lesage S, Rybojad M, Prieur AM, Manouvrier-Hanu S, Hafner R, Chamaillard M, Zouali H, Thomas G, Hugot JP (2001) CARD15 mutations in Blau syndrome. Nat Genet 29:19–20
Moers C, Smits JM, Maathuis MH, Treckmann J, van Gelder F, Napieralski BP, van Kasterop-Kutz M, van der Heide JJ, Squifflet JP, van Heurn E, Kirste GR, Rahmel A, Leuvenink HG, Paul A, Pirenne J, Ploeg RJ (2009) Machine perfusion or cold storage in deceased-donor kidney transplantation. N Engl J Med 360:7–19
Mullick AE, Tobias PS, Curtiss LK (2005) Modulation of atherosclerosis in mice by Toll-like receptor 2. J Clin Invest 115:3149–3156
Nemoto T, Burne MJ, Daniels F, O'Donnell MP, Crosson J, Berens K, Issekutz A, Kasiske BL, Keane WF, Rabb H (2001) Small molecule selectin ligand inhibition improves outcome in ischemic acute renal failure. Kidney Int 60:2205–2214
Nijboer WN, Schuurs TA, van der Hoeven JA, Fekken S, Wiersema-Buist J, Leuvenink HG, Hofker S, Homan van der Heide JJ, van Son WJ, Ploeg RJ (2004) Effect of brain death on gene expression and tissue activation in human donor kidneys. Transplantation 78:978–986
Nishiya T, Kajita E, Miwa S, Defranco AL (2005) TLR3 and TLR7 are targeted to the same intracellular compartments by distinct regulatory elements. J Biol Chem 280:37107–37117
Ogura Y, Inohara N, Benito A, Chen FF, Yamaoka S, Nunez G (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem 276:4812–4818
Ogura Y, Lala S, Xin W, Smith E, Dowds TA, Chen FF, Zimmermann E, Tretiakova M, Cho JH, Hart J, Greenson JK, Keshav S, Nunez G (2003) Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52:1591–1597
Ollinger R, Kogler P, Biebl M, Sieb M, Sucher R, Bosmuller C, Troppmair J, Mark W, Weiss H, Margreiter R (2008) Protein levels of heme oxygenase-1 during reperfusion in human kidney transplants with delayed graft function. Clin Transplant 22:418–423
Ollinger R, Pratschke J (2010) Role of heme oxygenase-1 in transplantation. Transpl Int 23:1071–1081
Ozturk H, Tuncer MC, Buyukbayram H (2007) Nitric oxide regulates expression of sonic hedgehog and hypoxia-inducible factor-1alpha in an experimental model of kidney ischemia-reperfusion. Ren Fail 29:249–256
Park P, Haas M, Cunningham PN, Alexander JJ, Bao L, Guthridge JM, Kraus DM, Holers VM, Quigg RJ (2001) Inhibiting the complement system does not reduce injury in renal ischemia reperfusion. J Am Soc Nephrol 12:1383–1390
Park P, Haas M, Cunningham PN, Bao L, Alexander JJ, Quigg RJ (2002) Injury in renal ischemia-reperfusion is independent from immunoglobulins and T lymphocytes. Am J Physiol Ren Physiol 282:F352–F357
Patole PS, Grone HJ, Segerer S, Ciubar R, Belemezova E, Henger A, Kretzler M, Schlondorff D, Anders HJ (2005) Viral double-stranded RNA aggravates lupus nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells. J Am Soc Nephrol 16:1326–1338
Patole PS, Pawar RD, Lech M, Zecher D, Schmidt H, Segerer S, Ellwart A, Henger A, Kretzler M, Anders HJ (2006) Expression and regulation of Toll-like receptors in lupus-like immune complex glomerulonephritis of MRL-Fas(lpr) mice. Nephrol Dial Transplant 21:3062–3073
Pratschke J, Tullius SG, Neuhaus P (2004) Brain death associated ischemia/reperfusion injury. Ann Transplant 9:78–80
Pratschke J, Neuhaus P, Tullius SG (2005) What can be learned from brain-death models? Transpl Int 18:15–21
Rabb H, Mendiola CC, Saba SR, Dietz JR, Smith CW, Bonventre JV, Ramirez G (1995) Antibodies to ICAM-1 protect kidneys in severe ischemic reperfusion injury. Biochem Biophys Res Commun 211:67–73
Raza A, Dikdan G, Desai KK, Shareef A, Fernandes H, Aris V, de la Torre AN, Wilson D, Fisher A, Soteropoulos P, Koneru B (2010) Global gene expression profiles of ischemic preconditioning in deceased donor liver transplantation. Liver Transplant 16:588–599
Robson MG (2009) Toll-like receptors and renal disease. Nephron Exp Nephrol 113:e1–e7
Rojas-Pena A, Reoma JL, Krause E, Boothman EL, Padiyar NP, Cook KE, Bartlett RH, Punch JD (2010) Extracorporeal support: improves donor renal graft function after cardiac death. Am J Transplant 10:1365–1374
Rosendale JD, Kauffman HM, McBride MA, Chabalewski FL, Zaroff JG, Garrity ER, Delmonico FL, Rosengard BR (2003) Aggressive pharmacologic donor management results in more transplanted organs. Transplantation 75:482–487
Salahudeen AK (2004) Consequences of cold ischemic injury of kidneys in clinical transplantation. J Investig Med 52:296–298
Salahudeen AK, Haider N, May W (2004) Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney Int 65:713–718
Salim A, Martin M, Brown C, Rhee P, Demetriades D, Belzberg H (2006) The effect of a protocol of aggressive donor management: Implications for the national organ donor shortage. J Trauma 61:429–433, discussion 433–425
Salmela K, Wramner L, Ekberg H, Hauser I, Bentdal O, Lins LE, Isoniemi H, Backman L, Persson N, Neumayer HH, Jorgensen PF, Spieker C, Hendry B, Nicholls A, Kirste G, Hasche G (1999) A randomized multicenter trial of the anti-ICAM-1 monoclonal antibody (enlimomab) for the prevention of acute rejection and delayed onset of graft function in cadaveric renal transplantation: a report of the European Anti-ICAM-1 Renal Transplant Study Group. Transplantation 67:729–736
Schnuelle P, Gottmann U, Hoeger S, Boesebeck D, Lauchart W, Weiss C, Fischereder M, Jauch KW, Heemann U, Zeier M, Hugo C, Pisarski P, Kramer BK, Lopau K, Rahmel A, Benck U, Birck R, Yard BA (2009) Effects of donor pretreatment with dopamine on graft function after kidney transplantation: a randomized controlled trial. JAMA 302:1067–1075
Shaw MH, Reimer T, Kim YG, Nunez G (2008) NOD-like receptors (NLRs): bona fide intracellular microbial sensors. Curr Opin Immunol 20:377–382
Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, Tobias PS, Mackman N, McKay DB (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and -independent pathways. J Immunol 178:6252–6258
Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva CJ, Ulevitch RJ, McKay DB (2010) Nod1 and nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 184:2297–2304
Shigeoka AA, Mueller JL, Kambo A et al (2010) An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 185:6277–6285
Shingu C, Koga H, Hagiwara S, Matsumoto S, Goto K, Yokoi I, Noguchi T (2010) Hydrogen-rich saline solution attenuates renal ischemia-reperfusion injury. J Anesth 24:569–574
Smith KD (2009) Toll-like receptors in kidney disease. Curr Opin Nephrol Hypertens 18:189–196
Snoeijs MG, Vink H, Voesten N et al (2010) Acute ischemic injury to the renal microvasculature in human kidney transplantation. Am J Physiol Ren Physiol 299:F1134–F1140
Solez K, Morel-Maroger L, Sraer JD (1979) The morphology of "acute tubular necrosis" in man: analysis of 57 renal biopsies and a comparison with the glycerol model. Medicine (Baltimore) 58:362–376
Soos TJ, Sims TN, Barisoni L et al (2006) CX(3)CR1(+) interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70:591–596
Stewart ZA, Cameron AM, Singer AL, Dagher NN, Montgomery RA, Segev DL (2009) Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival in pancreas transplantation. Am J Transplant 9:217–221
Stewart ZA, Cameron AM, Singer AL, Montgomery RA, Segev DL (2009) Histidine-Tryptophan-Ketoglutarate (HTK) is associated with reduced graft survival in deceased donor livers, especially those donated after cardiac death. Am J Transplant 9:286–293
Stewart ZA, Lonze BE, Warren DS, Dagher NN, Singer AL, Montgomery RA, Segev DL (2009) Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants. Am J Transplant 9:1048–1054
Suzuki H, Suzuki Y, Narita I, Aizawa M, Kihara M, Yamanaka T, Kanou T, Tsukaguchi H, Novak J, Horikoshi S, Tomino Y (2008) Toll-like receptor 9 affects severity of IgA nephropathy. J Am Soc Nephrol 19:2384–2395
Tada H, Aiba S, Shibata K, Ohteki T, Takada H (2005) Synergistic effect of Nod1 and Nod2 agonists with toll-like receptor agonists on human dendritic cells to generate interleukin-12 and T helper type 1 cells. Infect Immun 73:7967–7976
Tattoli I, Travassos LH, Carneiro LA, Magalhaes JG, Girardin SE (2007) The Nodosome: Nod1 and Nod2 control bacterial infections and inflammation. Semin Immunopathol 29:289–301
Terasaki PI, Cho YW, Cecka JM (1997) Strategy for eliminating the kidney shortage. Clin Transpl:265–267
Thurman JM, Ljubanovic D, Royer PA, Kraus DM, Molina H, Barry NP, Proctor G, Levi M, Holers VM (2006) Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest 116:357–368
Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA, Hoffman HM, Hugot JP, Inohara N, Mackenzie A, Maltais LJ, Nunez G, Ogura Y, Otten LA, Philpott D, Reed JC, Reith W, Schreiber S, Steimle V, Ward PA (2008) The NLR gene family: a standard nomenclature. Immunity 28:285–287
Ting JP, Willingham SB, Bergstralh DT (2008) NLRs at the intersection of cell death and immunity. Nat Rev Immunol 8:372–379
Totsuka E, Dodson F, Urakami A, Moras N, Ishii T, Lee MC, Gutierrez J, Gerardo M, Molmenti E, Fung JJ (1999) Influence of high donor serum sodium levels on early postoperative graft function in human liver transplantation: effect of correction of donor hypernatremia. Liver Transplant Surg 5:421–428
Treckmann J, Minor T, Saad S, Ozcelik A, Malago M, Broelsch CE, Paul A (2008) Retrograde oxygen persufflation preservation of human livers: a pilot study. Liver Transplant 14:358–364
Tsuboi N, Yoshikai Y, Matsuo S, Kikuchi T, Iwami K, Nagai Y, Takeuchi O, Akira S, Matsuguchi T (2002) Roles of toll-like receptors in C-C chemokine production by renal tubular epithelial cells. J Immunol 169:2026–2033
Uehara A, Sugawara Y, Kurata S, Fujimoto Y, Fukase K, Kusumoto S, Satta Y, Sasano T, Sugawara S, Takada H (2005) Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell Microbiol 7:675–686
Uehara A, Fujimoto Y, Fukase K, Takada H (2007) Various human epithelial cells express functional Toll-like receptors, NOD1 and NOD2 to produce anti-microbial peptides, but not proinflammatory cytokines. Mol Immunol 44:3100–3111
Velazquez P, Dustin ML, Nelson PJ (2009) Renal dendritic cells: an update. Nephron Exp Nephrol 111:e67–e71
Vergoulas G, Boura P, Efstathiadis G (2009) Brain dead donor kidneys are immunologically active: is intervention justified? Hippokratia 13:205–210
von Bernuth H, Picard C, Jin Z, Pankla R, Xiao H, Ku CL, Chrabieh M, Mustapha IB, Ghandil P, Camcioglu Y, Vasconcelos J, Sirvent N, Guedes M, Vitor AB, Herrero-Mata MJ, Arostegui JI, Rodrigo C, Alsina L, Ruiz-Ortiz E, Juan M, Fortuny C, Yague J, Anton J, Pascal M, Chang HH, Janniere L, Rose Y, Garty BZ, Chapel H, Issekutz A, Marodi L, Rodriguez-Gallego C, Banchereau J, Abel L, Li X, Chaussabel D, Puel A, Casanova JL (2008) Pyogenic bacterial infections in humans with MyD88 deficiency. Science 321:691–696
Voss E, Wehkamp J, Wehkamp K, Stange EF, Schroder JM, Harder J (2006) NOD2/CARD15 mediates induction of the antimicrobial peptide human beta-defensin-2. J Biol Chem 281:2005–2011
Weiss S, Kotsch K, Francuski M, Reutzel-Selke A, Mantouvalou L, Klemz R, Kuecuek O, Jonas S, Wesslau C, Ulrich F, Pascher A, Volk HD, Tullius SG, Neuhaus P, Pratschke J (2007) Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am J Transplant 7:1584–1593
Wijnen RM, Booster MH, Stubenitsky BM, de Boer J, Heineman E, Kootstra G (1995) Outcome of transplantation of non-heart-beating donor kidneys. Lancet 345:1067–1070
Wilhelm MJ, Pratschke J, Laskowski IA, Paz DM, Tilney NL (2000) Brain death and its impact on the donor heart-lessons from animal models. J Heart Lung Transplant 19:414–418
Willingham SB, Bergstralh DT, O'Connor W, Morrison AC, Taxman DJ, Duncan JA, Barnoy S, Venkatesan MM, Flavell RA, Deshmukh M, Hoffman HM, Ting JP (2007) Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe 2:147–159
Wood KE, Becker BN, McCartney JG, D'Alessandro AM, Coursin DB (2004) Care of the potential organ donor. N Engl J Med 351:2730–2739
Yang B, Hosgood SA, Harper SJ, Nicholson ML (2010) Leucocyte depletion improves renal function in porcine kidney hemoreperfusion through reduction of myeloperoxidase + cells, caspase-3, IL-1beta, and tubular apoptosis. J Surg Res 164:e315–e324
Yoshida J, Ozaki KS, Nalesnik MA, Ueki S, Castillo-Rama M, Faleo G, Ezzelarab M, Nakao A, Ekser B, Echeverri GJ, Ross MA, Stolz DB, Murase N (2010) Ex vivo application of carbon monoxide in UW solution prevents transplant-induced renal ischemia/reperfusion injury in pigs. Am J Transplant 10:763–772
Zhang ZX, Shek K, Wang S, Huang X, Lau A, Yin Z, Sun H, Liu W, Garcia B, Rittling S, Jevnikar AM (2010) Osteopontin expressed in tubular epithelial cells regulates NK cell-mediated kidney ischemia reperfusion injury. J Immunol 185:967–973
Zheng J, Devalaraja-Narashimha K, Singaravelu K, Padanilam BJ (2005) Poly(ADP-ribose) polymerase-1 gene ablation protects mice from ischemic renal injury. Am J Physiol Ren Physiol 288:F387–F398
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is published as part of the Special Issue on Transplantation and Tolerance.
Rights and permissions
About this article
Cite this article
McKay, D.B. The role of innate immunity in donor organ procurement. Semin Immunopathol 33, 169–184 (2011). https://doi.org/10.1007/s00281-011-0254-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00281-011-0254-z